Our News on Newswise

Newswise: 61eed61beb4b8_Grifoni_small.png

Current vaccines teach T cells to fight Omicron

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize...
24-Jan-2022 11:55 AM EST Add to Favorites

Newswise: 61e703a70b44a_Cystic fibrosis.png

Partial bone marrow transplant 'rescues' mice with cystic fibrosis

Scientists at La Jolla Institute for Immunology (LJI) have found they can dramatically improve survival of mice with cystic fibrosis through a partial bone marrow transplant. Their new study in the Journal of Immunology shows that a partial bone...
18-Jan-2022 1:35 PM EST Add to Favorites

Newswise: 61e1ebd81658a_DJI_0045.JPG

La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc.

La Jolla Institute for Immunology (LJI) and Kyowa Kirin, Inc. (KKNA), a wholly-owned subsidiary of Kyowa Kirin Co., Ltd (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, today announced the signing of a new collaboration...
18-Jan-2022 10:00 AM EST Add to Favorites

Macrophages in the artery wall 'smell' their surroundings

An artery is not like a nose. Or is it? Scientists at La Jolla Institute for Immunology (LJI) have discovered that immune cells in arteries can "sniff" out their surroundings and cause inflammation.
10-Jan-2022 11:55 AM EST Add to Favorites

Newswise: 61d605cd57cad_Shresta_Kim.png

LJI and Charles River Laboratories to collaborate on COVID-19 research

Scientists at La Jolla Institute for Immunology (LJI) and Charles River Laboratories International, Inc., are launching a new project to uncover exactly how different cells in the human immune system respond to SARS-CoV-2, the virus that causes...
6-Jan-2022 6:00 AM EST Add to Favorites

Newswise: 61c494711c543_Screen Shot 2021-12-22 at 6.51.59 PM.png

Strange DNA structures may drive cancer development

Scientists at the La Jolla Institute for Immunology (LJI) have uncovered how loss of TET enzymes can lead to B cell lymphoma. Their research, published in Nature Immunology, could potentially open opportunities for designing drug treatment...
23-Dec-2021 10:45 AM EST Add to Favorites

Newswise: 61b787ce539e6_2021_BCG_small.png

Once upon a BCG vaccine

A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering.
13-Dec-2021 1:10 PM EST Add to Favorites

Newswise: Low-Res_vaccination.png.png

New vaccine ingredient shows promise

Scientists at La Jolla Institute for Immunology (LJI) and Massachusetts Institute of Technology (MIT), have found a possible way to improve the effectiveness of COVID-19 vaccines—and any vaccine.
2-Dec-2021 8:05 PM EST Add to Favorites


See All News

Our Experts on Newswise

Newswise: EricaSaphire-139_p.jpg

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: 2018Dr.MatthiasvonHerrath.jpg

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Contacts

Gina Kirchweger
Chief Communications Officer
allergy immunology

gina@lji.org

858-752-6640

Jenna Hambrick
Digital Strategist

jhambrick@lji.org

858.752.6645

Madeline McCurry-Schmidt
Science Writer

madeline@lji.org

619-438-2382

Twitter

close
0.2416